EU approves kids' use of Pfizer lung medicine

May 05, 2011 By LINDA A. JOHNSON , AP Business Writer

(AP) -- Drugmaker Pfizer Inc. said Thursday that the European commission has approved treating children with its medicine for a rare, deadly lung condition - a drug better known as Viagra.

The drug, Revatio, was approved in Europe about six years ago for treating adults with what's called pulmonary arterial hypertension, or in lung arteries. Now it can be given to children aged 1 to 17.

The medicine is better known as Viagra, the erectile dysfunction drug that quickly became a blockbuster for New York-based after it was approved in 1998.

Viagra, known chemically as sildenafil citrate, was originally developed to treat blood pressure problems. But when some men participating in clinical tests reported a welcome but unexpected side effect - better erections - researchers switched tracks and began focusing on it as an impotence treatment.

Viagra has since brought Pfizer many billions of dollars. It now generates close to $2 billion in annual sales, despite fierce competition from two heavily advertised rival pills, Levitra and Cialis.

A recent study in children found the formulation in Revatio reduced blood pressure in lung arteries and helped them breathe and function better.

Revatio is approved for adults with the lung condition in more than 50 countries, including the United States. Pfizer is now seeking approval in numerous countries for treating children with .

The rare, leads to and premature death. Its cause can't always be determined.

"These young patients now have an important treatment option that may help manage their condition," Dr. Cara Cassino, head of Pfizer's medicines development group, said in a statement.

In the 234-patient study that led to the new European approval, side effects were similar to those in adults, including vomiting, nausea, fever, cough, abdominal pain and extreme .

Explore further: Xtoro approved for swimmer's ear

not rated yet
add to favorites email to friend print save as pdf

Related Stories

AIDS group objects to Viagra ads

Dec 14, 2006

An AIDS advocacy group in Los Angeles has asked the makers of Viagra to cease a marketing campaign that appears to promote the drug's recreational use.

Pfizer gets EU approval for kids' cholesterol drug

Jul 06, 2010

(AP) -- The European Union has approved a new chewable form of cholesterol blockbuster Lipitor for children 10 and up with high levels of bad cholesterol and triglycerides, a type of blood fat, Pfizer said Tuesday.

Pfizer drug found with serious side effect

Nov 01, 2006

U.S. pharmaceutical company Pfizer Inc. says clinical trials of its heart medication torcetrapib suggest the drug has a potentially serious side effect.

Citing liver damage, Pfizer withdraws Thelin

Dec 10, 2010

(AP) -- Pfizer Inc. said Friday it is pulling its blood pressure drug Thelin off the market and stopping all clinical trials because the drug can cause fatal liver damage.

Slovenia to launch generic version of Viagra

Jul 31, 2009

Krka, the biggest drugmaker in Slovenia, said Friday that its generic version of the impotency drug Viagra would be launched in September and priced 30 percent cheaper than the original.

Recommended for you

Xtoro approved for swimmer's ear

Dec 18, 2014

(HealthDay)—Xtoro (finafloxacin otic suspension) eardrops have been approved by the U.S. Food and Drug Administration to treat swimmer's ear, clinically known as acute otitis externa.

Drug interaction identified for ondansetron, tramadol

Dec 18, 2014

(HealthDay)—In the early postoperative period, ondansetron is associated with increased requirements for tramadol consumption, according to a review and meta-analysis published online Dec. 10 in Anaesthesia.

New system targets germs in donated blood plasma

Dec 17, 2014

(HealthDay)—A new system designed to eliminate germs in donated blood plasma and reduce the risk of transmitting a plasma-borne infection has been approved by the U.S. Food and Drug Administration.

Judge halts Alzheimer's drug swap until July

Dec 16, 2014

A federal judge has ordered an Irish drug manufacturer to halt its plans to discontinue its widely used Alzheimer's medication, allegedly in an effort to drive patients to a newer patented drug.

User comments : 1

Adjust slider to filter visible comments by rank

Display comments: newest first

dan42day
not rated yet May 06, 2011
That's the last thing I needed back when I was a teenager, I would have had to buy three legged pants!

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.